9-valent HPV (9vHPV) Vaccine Program Key Results

First Page		Document Content
Date: 2014-04-17 10:05:36 Gynaecological cancer Viral diseases HPV vaccine Gardasil Human papillomavirus Cervical cancer Vulvar intraepithelial neoplasia Vaginal intraepithelial neoplasia Cervical intraepithelial neoplasia Papillomavirus Medicine Vaccines		9-valent HPV (9vHPV) Vaccine Program Key Results Add to Reading List Source URL: www.cdc.gov Download Document from Source Website File Size: 255,99 KB Share Document on Facebook

	INTRODUCTION Anogenital human papillomavirus (HPV) infections are nearly ubiquitous among sexually active individuals: data indicate that up to 80% of sexually active persons experience one or more anogenital HPV infect DocID: 1rtdm - View Document
	Elvira Ann Marano August 20, October 27, 2010 DocID: 1rpU4 - View Document
	PDF Document DocID: 1rmwK - View Document
	Be Healthy Wellness Benefits Be Healthy– DocID: 1rifu - View Document
	Invited Speaker Seminar Title: Combining decision modeling and epidemiologic studies to determine optimal cervical cancer control policies in the era of HPV vaccines. Speaker: Shalini Kulasingam, PhD Host: Prof David Mat DocID: 1re0N - View Document